Neha Jodhawat: Advancing Precision Medicine in Immune Thrombocytopenia at ISTH 2026
Neha Jodhawat, PhD scholar at ICMR-National Institute of Immunohaematology, shared a post on LinkedIn:
“Winding up the ISTH 2026, Paris !
I am delighted to share that I had an opportunity to present my work at the ISTH ‘Immune and genetic profiling as step toward precision medicine in pediatric immune thrombocytopenia’ !!
Thank you to Anusandhan National Research Foundation (ANRF) for giving me international Travel support, which enabled me to attend International Society on Thrombosis and Haemostasis (ISTH) , held from 11-15 July 2026 in Paris,France.
The conference was an excellent opportunity to interact with leading researchers in the field of Immune thrombocytopenia.
I would also like to thank my supervisor and Director Manisha Madkaikar and my institute ICMR-National Institute for Research on Blood and Immune Disorders, (ICMR-NIRBID) for their constant guidance and encouragement throughout!
Thankful and grateful!!”
Stay updated with Hemostasis Today.
-
Sep 4, 2026, 17:28Shinya Goto: When Cardiovascular Risk Gets Lower, RCTs Get Harder
-
Sep 4, 2026, 16:55New Orleans Is Calling ASH26 Is Near
-
Sep 4, 2026, 16:48ESC Congress 2026 – My Top 20 Lipidology Highlights Shaping the Future of Cardiovascular Prevention – Pablo Corral
-
Sep 4, 2026, 16:38Felice Gragnano։ Turning Cardiovascular Risk Into Action
-
Sep 4, 2026, 16:30Lisa Littner: The Hidden Burden of Prior Authorization in Bleeding Disorder Care
-
Sep 4, 2026, 13:54Ahmad G. Alzahrani: A New Classification for Acute Pulmonary Embolism
-
Sep 4, 2026, 12:52James P. Crowley: MDS vs MPN – Understanding the Difference
-
Sep 4, 2026, 12:02Khalid Abdelsamea Mohamedahmed: Routine Blood Parameters in Pediatric Sickle Cell Anemia
-
Sep 4, 2026, 11:37Consuela A. Albright: The Power of Community Advocacy in Sickle Cell Disease